UK UPDATES OVER THE NEXT 7 DAYS

FULL-YEAR RESULTS

21 March: Kingfisher, Oxford Nanopore Technologies, Fintel, Ergomed, Alliance Pharma, Zotefoams, Kape Technologies, Tissue Regenix, Luceco, Gamma Communications, Aptitude Software, Quixant, Henry Boot, Equals, Staffline

22 March: Hostelworld, Ten Entertainment, Vistry, Fevertree Drinks, Pendragon, LSL Property Services, Anpario, MPAC, Genel Energy, Judges Scientific, Essentra, BioPharma Credit

23 March: Playtech, Portmeirion, Safestyle, Sopheon, Pollen Street

HALF-YEAR RESULTS

20 March: SCS, YouGov

23 March: Smiths Group

TRADING UPDATES

22 March: Bloomsbury Publishing

Can the posh mixers maker regain some fizz when it posts 2022 results?

After enjoying years of fizzing earnings upgrades and share price gains off the back of its 2014 stock market listing, posh mixers maker Fevertree (FEVR:AIM) has gone flat in recent times.

In January the company downgraded 2023 guidance thanks to rising costs – this negative news coming off the back of three profit warnings in 2022.

A key selling point for Fevertree and